HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jesper V Olsen Selected Research

Neuroblastoma

4/2021Proteomic investigation of Cbl and Cbl-b in neuroblastoma cell differentiation highlights roles for SHP-2 and CDK16.
11/2018Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma.
4/2015Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jesper V Olsen Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 01/2003
3Neuroblastoma
04/2021 - 04/2015
3Breast Neoplasms (Breast Cancer)
01/2018 - 09/2013
3Genomic Instability
01/2018 - 03/2014
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 03/2020
2Heart Diseases (Heart Disease)
01/2021 - 06/2013
2Fanconi Anemia (Fanconi's Anemia)
01/2019 - 01/2015
2Adenocarcinoma
01/2019 - 09/2014
2Obesity
06/2017 - 12/2012
2Neoplasm Metastasis (Metastasis)
01/2017 - 09/2014
2Inflammation (Inflammations)
01/2016 - 09/2014
1Multiple System Atrophy
06/2022
1Parkinsonian Disorders (Parkinsonism)
06/2022
1Brain Ischemia (Cerebral Ischemia)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Lung Neoplasms (Lung Cancer)
10/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Body Remains
01/2019
1Calculi (Calculus)
11/2018
1Intellectual Disability (Idiocy)
01/2018
1Communicable Diseases (Infectious Diseases)
06/2017
1Starvation
06/2017
1Ovarian Neoplasms (Ovarian Cancer)
01/2017
1Ewing Sarcoma (Sarcoma, Ewing)
01/2017
1Melanoma (Melanoma, Malignant)
01/2017
1Periodontitis
01/2016
1Dental Caries (Decay, Dental)
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2014
1Periodontal Diseases (Periodontal Disease)
04/2014
1Colorectal Neoplasms (Colorectal Cancer)
09/2013
1Down Syndrome (Down's Syndrome)
06/2013
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2013
1Hypertension (High Blood Pressure)
06/2013
1Cardiac Arrhythmias (Arrythmia)
06/2013
1Narcolepsy
08/2012
1Alcoholism (Alcohol Abuse)
08/2012
1Hypersensitivity (Allergy)
04/2012
1Ataxia Telangiectasia (Louis Bar Syndrome)
12/2011
1Cardiovascular Diseases (Cardiovascular Disease)
07/2010
1Carcinogenesis
01/2010

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2008
10Phosphotransferases (Kinase)IBA
01/2022 - 07/2009
7ProteomeIBA
06/2022 - 02/2007
6Pharmaceutical PreparationsIBA
01/2017 - 01/2009
5UbiquitinIBA
04/2021 - 03/2014
3Tyrosine (L-Tyrosine)FDA Link
10/2019 - 06/2013
3Protein Kinases (Protein Kinase)IBA
07/2009 - 08/2008
2Complement System Proteins (Complement)IBA
06/2022 - 01/2016
2Drug CombinationsIBA
01/2022 - 01/2017
2tyrosine receptor (receptor, tyrosine)IBA
01/2022 - 07/2009
2Transcription Factors (Transcription Factor)IBA
11/2018 - 01/2017
2Peptides (Polypeptides)IBA
12/2012 - 12/2011
1Protein Tyrosine PhosphatasesIBA
01/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2021
1Ligases (Synthetase)IBA
04/2021
13-hydroxycyclopent-1-enecarboxylic acidIBA
01/2021
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2021
1ChromatinIBA
01/2019
1Small Interfering RNA (siRNA)IBA
11/2018
1indolepropanol phosphate (IPP)IBA
11/2018
1NVP-TAE684IBA
11/2018
1ceritinibIBA
11/2018
1CrizotinibIBA
11/2018
1Anaplastic Lymphoma KinaseIBA
11/2018
1Tyrosine Kinase InhibitorsIBA
11/2018
1lorlatinibIBA
11/2018
1Insulin Receptor Substrate ProteinsIBA
11/2018
1Indicators and Reagents (Reagents)IBA
06/2017
1Eosinophil PeroxidaseIBA
06/2017
1midostaurinIBA
01/2017
1Deubiquitinating EnzymesIBA
01/2017
1EWS-FLI fusion proteinIBA
01/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2017
1Epidermal Growth Factor (EGF)IBA
01/2016
1TropomyosinIBA
04/2015
1Nerve Growth Factor (NGF)IBA
04/2015
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2015
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2015
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2015
1EnzymesIBA
01/2015
1Carrier Proteins (Binding Protein)IBA
01/2015
1Biological ProductsIBA
09/2014
1GlycosyltransferasesIBA
09/2014
1Polysaccharides (Glycans)IBA
09/2014
1Immunologic Factors (Immunomodulators)IBA
04/2014
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
09/2013
1Tissue Inhibitor of Metalloproteinase-1IBA
09/2013
1Topoisomerase InhibitorsIBA
09/2013
1Adrenergic Receptors (Adrenergic Receptor)IBA
06/2013
1SecretinFDA Link
12/2012
1Glucagon-Like Peptide 1 (GLP 1)IBA
12/2012
1NeurotensinIBA
12/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2012
1Therapeutic UsesIBA
08/2012
1DNA (Deoxyribonucleic Acid)IBA
04/2012
1Type 1 Angiotensin ReceptorIBA
07/2010
1GTP-Binding Proteins (G-Protein)IBA
07/2010

Therapy/Procedure

3Therapeutics
04/2021 - 01/2017
1Castration
01/2019
1Drug Therapy (Chemotherapy)
09/2013